©The Author(s) 2025.
World J Diabetes. Dec 15, 2025; 16(12): 112580
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112580
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112580
Figure 1 Graphical abstract.
Clinical challenges (left), multi-target stimulation of key acupuncture points (middle), and potential mechanisms involving the nervous system, anti-inflammation, gut microbiota, and insulin signaling pathways (right) ultimately contribute to the development of future closed-loop wearable devices for personalized management. CGM: Continuous glucose monitoring; IL-1β: Interleukin-1β; SCFA: Short-chain fatty acid; LPS: Lipopolysaccharide. Created with biorender.com (Supplementary material).
- Citation: Wang SY, Deng CX, Huang YN, Tian MX, Zhuang SY, Deng YF, Xu B, Xu TC. Electroacupuncture in glycemic control: Transitioning from clinical controversies to potential basic research. World J Diabetes 2025; 16(12): 112580
- URL: https://www.wjgnet.com/1948-9358/full/v16/i12/112580.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i12.112580